Johnson & Johnson (JNJ) vs The Coca-Cola Company (KO)

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.

Founded in 1886 and headquartered in Atlanta, The Coca-Cola Company is the world’s largest nonalcoholic beverage company, with a broad portfolio of 200 brands spanning major categories such as carbonated soft drinks, water, sports drinks, energy drinks, juice, and coffee. Through its bottling operations and distribution partners, Coca-Cola markets finished beverage products under its own and licensed brands via retailers and food-service outlets in more than 200 countries and regions worldwide. Approximately 60% of the company’s total revenue comes from international markets, with significant contributions from emerging economies in Latin America and the Asia-Pacific region.